Published in Am J Clin Pathol on October 01, 2001
"In situ-like" mantle cell lymphoma: a report of two cases. J Clin Pathol (2006) 1.03
Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden. J Hematop (2012) 0.88
Mantle Cell Hyperplasia of Peripheral Lymph Nodes as Initial Manifestation of Sickle Cell Disease. Case Rep Hematol (2016) 0.75
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol (1998) 4.92
Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med (1995) 3.31
Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol (1998) 3.21
Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood (1999) 2.95
Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med (1995) 2.85
Regulation of the L-arabinose operon BAD in vitro. J Biol Chem (1974) 2.68
Familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst (2001) 2.62
Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med (1997) 2.45
A case-control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in eastern Nebraska. Epidemiology (1990) 2.40
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol (2002) 2.28
Extramedullary myeloid cell tumors. An immunohistochemical and morphologic study of 28 cases. Am J Surg Pathol (1993) 2.20
Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States). Cancer Causes Control (1994) 2.07
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases. Am J Clin Pathol (1995) 2.02
Toward normative expert systems: Part I. The Pathfinder project. Methods Inf Med (1992) 1.97
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet (1999) 1.96
Specific genetic analysis of microscopic tissue after selective ultraviolet radiation fractionation and the polymerase chain reaction. Am J Pathol (1992) 1.91
Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood (1993) 1.82
Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol (1985) 1.79
Malignant lymphoma, lymphoblastic. Cancer (1976) 1.75
DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia (2008) 1.70
Integrative assessment of multiple pesticides as risk factors for non-Hodgkin's lymphoma among men. Occup Environ Med (2003) 1.70
BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci U S A (1994) 1.69
Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases. Cancer (1981) 1.65
Role of the herbicide atrazine in the development of non-Hodgkin's lymphoma. Scand J Work Environ Health (1993) 1.61
Drinking water nitrate and the risk of non-Hodgkin's lymphoma. Epidemiology (1996) 1.60
Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. Blood (1987) 1.56
Mutations affecting catabolite repression of the L-arabinose regulon in Escherichia coli B/r. J Bacteriol (1976) 1.55
Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. J Neuroimmunol (1997) 1.49
Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer (1978) 1.49
Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J Cereb Blood Flow Metab (1994) 1.49
Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Am J Public Health (1992) 1.48
Clonality analysis of B-lymphoid proliferations using the polymerase chain reaction. Cancer (1996) 1.47
Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer (1982) 1.46
Clonality in nodular lymphocyte-predominant Hodgkin's disease. N Engl J Med (1997) 1.46
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. Br J Cancer (2005) 1.45
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia (2007) 1.43
Ethylenediamine tetraacetic acid-associated leukoagglutination. Am J Clin Pathol (1995) 1.41
Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma. Cancer (1982) 1.41
Hodgkin's disease occurring in monocytoid B-cell clusters. Am J Clin Pathol (1991) 1.40
Nerve growth factor receptor expression on dendritic reticulum cells in follicular lymphoid proliferations. Hum Pathol (1991) 1.40
Lymphomas with follicular and monocytoid B-cell components. Evidence for a common clonal origin from follicle center cells. Am J Clin Pathol (2000) 1.40
Transient stress lymphocytosis during crisis of sickle cell anemia and emergency trauma and medical conditions. An immunophenotyping study. Arch Pathol Lab Med (1990) 1.39
Marginal zone B-cell lymphomas: an appraisal. Hum Pathol (1997) 1.39
Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood (1994) 1.38
Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. J Clin Oncol (1990) 1.37
Bone marrow aspiration and trephine biopsy. An approach to a thorough study. Am J Clin Pathol (1978) 1.37
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood (1992) 1.36
An evaluation of the diagnostic accuracy of Pathfinder. Comput Biomed Res (1992) 1.33
Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer (1997) 1.32
Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals. Analysis of fixed tissue using the polymerase chain reaction. Am J Pathol (1989) 1.31
Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res (1995) 1.29
Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc Natl Acad Sci U S A (2001) 1.29
Value of lymph node biopsy in unexplained lymphadenopathy in homosexual men. JAMA (1983) 1.28
The role of agricultural pesticide use in the development of non-Hodgkin's lymphoma in women. Arch Environ Health (1993) 1.28
Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med (1987) 1.27
Toward normative expert systems: Part II. Probability-based representations for efficient knowledge acquisition and inference. Methods Inf Med (1992) 1.25
Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury. J Cereb Blood Flow Metab (1996) 1.23
Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. Mod Pathol (1999) 1.23
Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies. J Clin Oncol (1985) 1.20
Mesocolic lymph node histology is an important prognostic indicator for patients with carcinoma of the sigmoid colon: an immunomorphologic study. Cancer (1975) 1.19
Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes. Blood (1986) 1.17
Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer (2013) 1.17
Remission of giant lymph node hyperplasia with anemia after radiotherapy. Cancer (1979) 1.16
p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood (1996) 1.16
Agricultural use of organophosphate pesticides and the risk of non-Hodgkin's lymphoma among male farmers (United States). Cancer Causes Control (2001) 1.14
Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol (1999) 1.13
Angioimmunoblastic lymphadenopathy. Long-term follow-up study. Cancer (1983) 1.13
Osteitis fibrosa cystica simulating metastatic tumor. An almost-forgotten relationship. Am J Clin Pathol (1993) 1.12
The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. J Clin Oncol (1988) 1.11
The tumor cells in nodular lymphocyte-predominant Hodgkin disease are clonally related to the large cell lymphoma occurring in the same individual. Direct demonstration by single cell analysis. Am J Clin Pathol (2001) 1.10
A critical analysis of the classifications of non-Hodgkin's lymphomas. Cancer (1979) 1.09
Towards understanding the peripheral T-cell lymphomas. Ann Oncol (2004) 1.09
Monoclonal antibodies marking T lymphocytes in paraffin-embedded tissue. Am J Pathol (1987) 1.09
High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood (1989) 1.09
Kikuchi-Fujimoto disease mimicking malignant lymphoma. Am J Surg Pathol (1990) 1.08
Monoclonal small (well-differentiated) lymphocytic proliferations of the gastrointestinal tract resembling lymphoid hyperplasia: a neoplasm of uncertain malignant potential. Hum Pathol (1987) 1.08
Agricultural exposure to carbamate pesticides and risk of non-Hodgkin lymphoma. J Occup Environ Med (2001) 1.07
Autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant (2000) 1.06
Pathology of autoimmune myelofibrosis. A report of three cases and a review of the literature. Am J Clin Pathol (2001) 1.06
Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. Blood (1991) 1.06
The site for catabolite deactivation in the L-arabinose BAD operon in Escherichia coli B/r. Arch Microbiol (1976) 1.05
Inflammatory meningeal masses of unexplained origin. An ultrastructural and immunological study. J Neuropathol Exp Neurol (1983) 1.05
Indolent T-lymphoblastic proliferation: report of a case with a 16-year course without cytotoxic therapy. Am J Surg Pathol (1999) 1.05
Evolving characteristics of AIDS-related lymphoma. Blood (2000) 1.05
Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol (2000) 1.05